ProtoKinetix, Incorporated
PKTX - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$117.46K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $117,459.00 |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $0 |
| Beta | 0.73 |
| Outstanding Shares | 391,529,700 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -0.33 |
|---|---|
| PEG | -1.96 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.01%0% |
|---|---|
| Total Invested | $200▲ 117.39% |
| Investors Holding | 10% |
About ProtoKinetix, Incorporated
5 employees
CEO: Michael Richard Guzzetta
ProtoKinetix, Incorporated is a biotechnology firm engaged in research and development, specializing in the scientific and medical investigation of glycoproteins known as anti-freeze glycoproteins (AFGPs) and anti-aging glycoproteins (AA...